← Open Payments lookup

CHIDINMA EZE: Open Payments

NPI 1497283097 · MILLERSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,001 in 79 payments from 10 companies in 2025. Trend: 2023 $91 · 2024 $1,698 · 2025 $2,001

Food & beverage: $2,001
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.13$415
Neurocrine BioSciences, Inc.10$291
Alkermes, Inc.12$257
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$214
Otsuka America Pharmaceutical, Inc.9$201
Teva Pharmaceuticals USA, Inc.8$194
Lundbeck LLC7$149
Janssen Pharmaceuticals, Inc3$124
E.R. Squibb & Sons, L.L.C.5$104
ABBVIE INC.2$52

Products named: FANAPT, INGREZZA, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII, REXULTI, INVEGA SUSTENNA, HETLIOZ.

Industry payments across MD — which companies pay providers there.